Skip to main content

Month: July 2023

Iris Energy Announces Appointment of Sunita Parasuraman to Board of Directors

SYDNEY, Australia, July 18, 2023 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: IREN) (“Iris Energy” or “the Company”), a leading owner and operator of institutional-grade, highly efficient Bitcoin mining data centers powered by 100% renewable energy, today announced the appointment of Sunita Parasuraman to its Board of Directors. Ms. Parasuraman will also serve as Chair of the Audit and Risk Committee. During her career as a senior technology executive, Ms. Parasuraman has built and scaled world-class teams at Meta (Facebook), VMware, Genentech, and Apple. Ms. Parasuraman most recently served as the Head of Investments, New Product Experimentation at Meta (Facebook) and, prior to that, served as Facebook’s Global Head of Treasury and Head of Treasury for Facebook’s blockchain initiative (Libra). Ms. Parasuraman currently serves...

Continue reading

Emerging Markets Report: Credits to Credibility

DevvStream Well-Positioned in the ESG Industry and Looking to Go to the NASDAQ An Emerging Markets Sponsored Commentary ORLANDO, Fla., July 18, 2023 (GLOBE NEWSWIRE) — In today’s edition of The Emerging Markets Report we are pleased to introduce a Company quite unlike any others featured previously in our proverbial pages. And there is a lot to take in and to evaluate as the Company is making a massive move right now as they look to take their shares to the mighty NASDAQ. It makes today’s missive almost urgent, given what looms on the horizon. And if you care about the environment and want to feel good about your investing choices give us a moment to show you a Company with a business plan that’s based in protecting the world in which we live. O.K., first let’s start with a formal introduction. DevvStream Holdings Inc. (CBOE: DESG)...

Continue reading

Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology

Newly Assigned USAN Name, Oxylanthanum Carbonate, replaces Lanthanum Dioxycarbonate LOS ALTOS, Calif., July 18, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that the peer-reviewed international journal the American Journal of Nephrology has published positive results on the phosphate binding capacity for oxylanthanum carbonate (OLC). The Company also announced the adoption of the non-proprietary name, oxylanthanum carbonate (OLC) by the United States Adopted Name (USAN) organization, replacing lanthanum dioxycarbonate (LDC) which has been used in previous publications and company presentations. OLC is Unicycive’s investigational phosphate binding agent utilizing proprietary...

Continue reading

Landsea Homes Announces Private Placement of $250 million in Senior Unsecured Notes

DALLAS, July 18, 2023 (GLOBE NEWSWIRE) — Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”) announced today that it has entered into a note purchase agreement (“the Note Purchase Agreement”) with various investors, including funds and accounts managed by BlackRock Financial Management Inc. and affiliates thereof (“BlackRock”) and Angelo, Gordon & Co., L.P. (“Angelo Gordon”). The Note Purchase Agreement provides for the private placement of $250,000,000 aggregate principal amount of 11% senior notes due 2028 (the “Notes”). The Notes will be guaranteed, jointly and severally, on a senior unsecured basis, by most of the Company’s subsidiaries (the “Guarantors”) and will rank pari passu with all other unsecured and unsubordinated indebtedness of the Company and Guarantors.   The Company intends to use...

Continue reading

Nxu Demonstrates NACS Charging Capability, Highlighting Commitment to Developing Standard-Agnostic Charging Solutions

MESA, Ariz., July 18, 2023 (GLOBE NEWSWIRE) — Nxu Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a U.S. technology company manufacturing innovative battery cells and battery packs for advanced energy storage systems, megawatt charging stations, and mobility solutions, today announced its successful demonstration of North American Charging Standard (NACS) capability. Following Nxu’s endorsement of the industry’s move to NACS last month, the Company further demonstrated its commitment to developing standard-agnostic charging solutions by integrating the NACS charging cable and connector into its proprietary megawatt-plus charging and energy infrastructure solutions. Furthering its mission to accelerate mass market adoption of electric vehicles, Nxu is developing innovative megawatt-plus charging and energy infrastructure solutions....

Continue reading

Wind Tower Market Set to Soar Past USD 41.3 Billion by 2030 | Skyquest Technology

The wind tower market, including steel, concrete, and hybrid tower types, is projected to experience significant growth from 2023 to 2030. With applications in both offshore and onshore wind projects, the market offers promising opportunities for industry players. Westford, USA, July 18, 2023 (GLOBE NEWSWIRE) — The global Wind Tower market size is expected to reach USD 41.3 billion by 2030 and exhibit a CAGR of 7.6% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing global demand for renewable energy, government support and incentives for wind power development, growing concerns about climate change and carbon emissions, decreasing costs of wind energy generation, advancements in wind turbine technology and efficiency, expanding offshore wind energy projects, increasing investment...

Continue reading

Neurogene and Neoleukin Announce Definitive Merger Agreement

Proposed merger to create Nasdaq-listed biotech company focused on advancing Neurogene’s differentiated portfolio of genetic medicines for complex neurological diseasesCombined company is expected to have a cash balance of approximately $200 million at close, including approximately $95 million from concurrent private financing by Neurogene’s new and existing investorsCash expected to fund combined company into 2H:26 and through multiple catalysts, including preliminary data in 4Q:24 and additional data in 2H:25 from a Phase 1/2 clinical trial in Rett syndromeCompanies to host conference call today at 8:30 am ETNEW YORK and SEATTLE, July 18, 2023 (GLOBE NEWSWIRE) — Neurogene Inc., a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases,...

Continue reading

Goodfood Reports Third Quarter Results with $42 Million of Net Sales, $3 Million of Adjusted EBITDA¹ and Record $4 Million of Adjusted Free Cash Flow¹

Net sales were $42 million in the third quarter, a 37% reduction compared to the same quarter last year and an increase of $0.1 million compared to the second quarter of Fiscal 2023. Net sales results were driven by our deliberate focus on higher value customers leading to better unit economics Record quarterly unadjusted gross margin of 41.0%, an improvement of 14.8% compared to the same quarter last year, with gross profit at $17.3 million compared to $17.6 million in the same quarter last year, a slight decrease despite net sales declining 37% Net loss for the quarter was $1 million, a $20 million improvement compared to the same quarter last year Record quarterly adjusted EBITDA margin1 of 7.8% for an adjusted EBITDA1 of $3 million this quarter, a $14 million improvement compared to the same quarter last year Cash flows from operations...

Continue reading

Biorefinery Market Size Expected to Rise $80.26 billion at CAGR 8.6% by 2029

Biorefinery Market to Reach USD 80.26 billion by 2029; Texas Announces 1.7 Billion Refinery Project to Enhance Fuel Production: Fortune Business Insights Pune, India, July 18, 2023 (GLOBE NEWSWIRE) — The global biorefinery market size was USD 41.88 billion in 2021. The market is expected to grow from USD 45.03 billion in 2022 to USD 80.26 billion by 2029 at a CAGR of 8.6% in the 2022-2029 period. This information is provided by Fortune Business Insights, in its report titled, “Biorefinery Market, 2022-2029.” Market Drivers & Restraints: Market Value to Surge Driven by Rapid Industrialization The biorefinery market growth is prominently driven by massive production rates and surging technological advancements. The product demand is further propelled by the escalating consumption of energy in the industrial sector. The increasing...

Continue reading

Unitil Schedules Second Quarter 2023 Earnings Release and Conference Call

HAMPTON, N.H., July 18, 2023 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its second quarter 2023 earnings before the market opens on August 1, 2023. Unitil will host its conference call and webcast later that day at 10:00 a.m. (ET) to review its quarterly results. Related presentation materials will be available before the call on the Company’s Investors page at investors.unitil.com. The conference call will be broadcast live in listen-only mode on the Company’s Investors page at investors.unitil.com. Interested parties may access dial information for the call by registering via web link here. An archive of the webcast will be available for one year on the website at investors.unitil.com. About Unitil Corporation Unitil Corporation provides energy for life by safely and reliably delivering...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.